Data collected on respondents aged 6 to 79 demonstrate that lung function increases rapidly during childhood and adolescence, in line with normal growth and development, followed by a gradual decline during adulthood caused by the normal deterioration associated with aging.
Lung function measurements, also known as spirometric measurements, are invaluable tools in the study of respiratory health and lung disease. They permit objective diagnosis of lung disease and assess and monitor disease severity by comparing measurements to the expected values for a normal individual of the same age, height, sex and ethnic origin.
The measurements of primary interest are

Source: Canadian Health Measures Survey (CHMS), 2007 to 2009
Males have larger FVC and FEV1 volumes in all age groups. This difference between the sexes is not significant in early childhood, however it increases significantly until early adulthood where it remains throughout late adulthood.
The ratio of FEV1 to FVC expresses the fraction of air that was exhaled in the first second of a FVC manoeuvre. This ratio is markedly age dependant, decreasing with age. Females have greater FEV1/FVC ratios than males at all ages except in the 40 to 59 age group.

Source: Canadian Health Measures Survey (CHMS), 2007 to 2009
Since normal lung function values do not exist for the Canadian population, one of the CHMS objectives is to provide nationally representative data on lung function to develop normative data for age, gender and racial groups. This information will enable experts to better estimate the prevalence of conditions related to low lung function and interpret lung function testing.
Spirometry is a test that measures the volume of air an individual inhales or exhales and the rate at which the air is moved into or out of the lungs.
Much like blood pressure provides important information about general cardiovascular health, spirometry is invaluable as a screening test of general respiratory health. Used in conjunction with other tests spirometry allows medical practitioners to monitor respiratory health for conditions such as chronic obstructive pulmonary disease (COPD) and cystic fibrosis.
Spirometry results are interpreted by comparing measurements to the expected values for a normal healthy individual with the same anthropometric and ethnic characteristics. In Canada, predominantly American data are used to define these normal and expected values.